Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT

Background: We aimed to develop and validate a preoperative CT-based radiomics signature for differentiating lymphoma versus benign splenomegaly. Methods: We retrospectively analyzed CT studies from 139 patients (age range 26–93 years, 43% female) between 2011 and 2019 with histopathological diagnos...

Full description

Bibliographic Details
Main Authors: Jih-An Cheng, Yu-Chun Lin, Yenpo Lin, Ren-Chin Wu, Hsin-Ying Lu, Lan-Yan Yang, Hsin-Ju Chiang, Yu-Hsiang Juan, Ying-Chieh Lai, Gigin Lin
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/24/3632
_version_ 1797381413099536384
author Jih-An Cheng
Yu-Chun Lin
Yenpo Lin
Ren-Chin Wu
Hsin-Ying Lu
Lan-Yan Yang
Hsin-Ju Chiang
Yu-Hsiang Juan
Ying-Chieh Lai
Gigin Lin
author_facet Jih-An Cheng
Yu-Chun Lin
Yenpo Lin
Ren-Chin Wu
Hsin-Ying Lu
Lan-Yan Yang
Hsin-Ju Chiang
Yu-Hsiang Juan
Ying-Chieh Lai
Gigin Lin
author_sort Jih-An Cheng
collection DOAJ
description Background: We aimed to develop and validate a preoperative CT-based radiomics signature for differentiating lymphoma versus benign splenomegaly. Methods: We retrospectively analyzed CT studies from 139 patients (age range 26–93 years, 43% female) between 2011 and 2019 with histopathological diagnosis of the spleen (19 lymphoma, 120 benign) and divided them into developing (<i>n</i> = 79) and testing (<i>n</i> = 60) datasets. The volumetric radiomic features were extracted from manual segmentation of the whole spleen on venous-phase CT imaging using PyRadiomics package. LASSO regression was applied for feature selection and development of the radiomic signature, which was interrogated with the complete blood cell count and differential count. All <i>p</i> values < 0.05 were considered to be significant. Results: Seven features were selected for constructing the radiomic signature after feature selection, including first-order statistics (10th percentile and Robust Mean Absolute Deviation), shape-based (Surface Area), and texture features (Correlation, MCC, Small Area Low Gray-level Emphasis and Low Gray-level Zone Emphasis). The radiomic signature achieved an excellent diagnostic accuracy of 97%, sensitivity of 89%, and specificity of 98%, distinguishing lymphoma versus benign splenomegaly in the testing dataset. The radiomic signature significantly correlated with the platelet and segmented neutrophil percentage. Conclusions: CT-based radiomics signature can be useful in distinguishing lymphoma versus benign splenomegaly and can reflect the changes in underlying blood profiles.
first_indexed 2024-03-08T20:52:10Z
format Article
id doaj.art-d1d90bfd6cbb469db2e2fe102c375fac
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-08T20:52:10Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-d1d90bfd6cbb469db2e2fe102c375fac2023-12-22T14:03:08ZengMDPI AGDiagnostics2075-44182023-12-011324363210.3390/diagnostics13243632Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CTJih-An Cheng0Yu-Chun Lin1Yenpo Lin2Ren-Chin Wu3Hsin-Ying Lu4Lan-Yan Yang5Hsin-Ju Chiang6Yu-Hsiang Juan7Ying-Chieh Lai8Gigin Lin9Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Pathology, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanClinical Trial Center, Chang Gung Memorial Hospital at Linkou and Chang Gung University, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanDepartment of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, 5 Fuhsing St., Guishan, Taoyuan 333, TaiwanBackground: We aimed to develop and validate a preoperative CT-based radiomics signature for differentiating lymphoma versus benign splenomegaly. Methods: We retrospectively analyzed CT studies from 139 patients (age range 26–93 years, 43% female) between 2011 and 2019 with histopathological diagnosis of the spleen (19 lymphoma, 120 benign) and divided them into developing (<i>n</i> = 79) and testing (<i>n</i> = 60) datasets. The volumetric radiomic features were extracted from manual segmentation of the whole spleen on venous-phase CT imaging using PyRadiomics package. LASSO regression was applied for feature selection and development of the radiomic signature, which was interrogated with the complete blood cell count and differential count. All <i>p</i> values < 0.05 were considered to be significant. Results: Seven features were selected for constructing the radiomic signature after feature selection, including first-order statistics (10th percentile and Robust Mean Absolute Deviation), shape-based (Surface Area), and texture features (Correlation, MCC, Small Area Low Gray-level Emphasis and Low Gray-level Zone Emphasis). The radiomic signature achieved an excellent diagnostic accuracy of 97%, sensitivity of 89%, and specificity of 98%, distinguishing lymphoma versus benign splenomegaly in the testing dataset. The radiomic signature significantly correlated with the platelet and segmented neutrophil percentage. Conclusions: CT-based radiomics signature can be useful in distinguishing lymphoma versus benign splenomegaly and can reflect the changes in underlying blood profiles.https://www.mdpi.com/2075-4418/13/24/3632computer-aided diagnosisquantitative imaging biomarkersradiomicslymphomasplenomegaly
spellingShingle Jih-An Cheng
Yu-Chun Lin
Yenpo Lin
Ren-Chin Wu
Hsin-Ying Lu
Lan-Yan Yang
Hsin-Ju Chiang
Yu-Hsiang Juan
Ying-Chieh Lai
Gigin Lin
Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
Diagnostics
computer-aided diagnosis
quantitative imaging biomarkers
radiomics
lymphoma
splenomegaly
title Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
title_full Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
title_fullStr Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
title_full_unstemmed Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
title_short Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT
title_sort machine learning radiomics signature for differentiating lymphoma versus benign splenomegaly on ct
topic computer-aided diagnosis
quantitative imaging biomarkers
radiomics
lymphoma
splenomegaly
url https://www.mdpi.com/2075-4418/13/24/3632
work_keys_str_mv AT jihancheng machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT yuchunlin machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT yenpolin machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT renchinwu machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT hsinyinglu machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT lanyanyang machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT hsinjuchiang machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT yuhsiangjuan machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT yingchiehlai machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct
AT giginlin machinelearningradiomicssignaturefordifferentiatinglymphomaversusbenignsplenomegalyonct